openPR Logo
Press release

Peptides and Heparin Market | Global Growing Players - Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm, Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., Bachem, Abbott Laboratories, Pfizer Inc., Aspen, Leo Pharma

09-26-2018 12:03 PM CET | Health & Medicine

Press release from: Fact.MR

Peptides and Heparin Market | Global Growing Players - Baxter,

Peptides are amino acids’ short chains connected through peptide bonds. Peptides are molecules that are commonly known as proteins, whose functions are determined on the basis of the amino acid sequence and size. Heparin is known as disaccharide anticoagulant, commonly referred to as blood thinner, which prevents formation of blood clots. Mast cells and basophils in a body produce heparin, which is stored in mast cells and secreted wherever injuries occur.

To Get Sample Copy of Report Click Here @ https://www.factmr.com/connectus/sample?flag=S&rep_id=378

Drug Developers Shifting Back to Peptides owing to Mounting Challenges regarding Small Molecules

While the pharmaceutical sector discerned small molecules as the medicinal agents, therapeutic peptides were considered to be niche products. However, with mounting challenges regarding small molecules, drug developers are shifting their concentration back to small amino acid chains. Although peptides have been deemed ineffective for developing drugs, modern peptide drug designs and formulations have been developed for circumventing their weaknesses. For example, original requirement for injecting peptides such as insulin is fading, with more patient-friendly administrations progressively being developed. In addition, the current society that critically judges undesirable effects and environmental impact of the candidate medicines is embracing the safety offered by peptides.

Heparin is being extensively employed as an antitumor and anti-inflammatory agent. The anti-inflammatory characteristic of heparin, which prevents metastatic spreading of tumor cells, is a new research finding among healthcare professionals. The metastatic spreading of tumor cells is restricted by heparin through neutralization of cationic mediators, inhibition of heparanase, and adhesion molecules. Recent discoveries have meant that heparin is capable of targeting L- and P-selectin & integrin activity, as well as preventing cancer progression.

A new report by Fact.MR projects the global peptide and heparin market to reflect an impressive expansion during the forecast period, 2017 to 2026. Revenues from the market are estimated to exceed US$ 34,000 Mn by 2026-end.

Browse Complete Report with TOC @ https://www.factmr.com/report/378/peptides-heparin-market

APEJ to Remain Most Remunerative Market for Peptide and Heparin

There has been a growing demand for new oral anticoagulants having better efficacy and safety profiles in Asia-Pacific excluding Japan (APEJ). Side effects related to heparin products, including complications of bleeding and heparin-induced thrombocytopenia has resulted into robust adoption of oral anticoagulants in the region. In addition, rising incidence of cancer, metabolic disorders, and hepatitis, along with advancements in peptide synthesis technology and rapid demand for various peptide therapies in the region are expected to drive the growth in APEJ. APEJ will remain the most remunerative market for peptide and heparin.

Liraglutide and ammonium heparin are expected to remain fast-expanding products in the market. In addition, sales of exenatide, lithium heparin, and sodium heparin will register a similar CAGR through 2026.

Key Research Findings from Fact.MR’s Report on Peptide and Heparin Market

Oral route of administration will remain preferred for peptide and heparin
Cancer will continue to be the dominant indication segment in the market, in terms of revenues
Hospital pharmacies will remain the most lucrative distribution channel for peptide and heparin
Competition Tracking

The global market for peptide and heparin is high fragmented and competitive owing to the presence of a large number of international and regional vendors. These vendors are continuously focusing on the development of generic formulations related to blood coagulation and several other novel therapeutic areas. Companies having the capability of manufacturing drugs for effective treatment of coagulation disorders, along with high efficacy and safety profiles are likely to gain maximum market shares in the foreseeable future. Key market participants identified by the report include Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm, Inc., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., Bachem, Abbott Laboratories, Pfizer Inc., Aspen, Leo Pharma, Teva, Takeda, Sanofi, Novo Nordisk, and Eli Lilly.

Enquire about this Report @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=378

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptides and Heparin Market | Global Growing Players - Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm, Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., Bachem, Abbott Laboratories, Pfizer Inc., Aspen, Leo Pharma here

News-ID: 1263689 • Views:

More Releases from Fact.MR

Allyl Polyether Market Expected to Grow at 4.5% CAGR to US$ 99.1 Million by 2033
Allyl Polyether Market Expected to Grow at 4.5% CAGR to US$ 99.1 Million by 2033
The global Allyl Polyether Market (アリルポリエーテル市場) was valued at approximately US$ 63.8 million in 2023 and is projected to reach around US$ 99.1 million by the end of 2033, growing at a compound annual growth rate (CAGR) of 4.5%. The Allyl Polyether Market is a segment of the polymer industry that has been witnessing steady growth in recent years. This growth can be attributed to several factors, including the increasing demand
Construction Aggregate Market to Surge at 6.5% CAGR Through 2034
Construction Aggregate Market to Surge at 6.5% CAGR Through 2034
The global Construction Aggregate Market (建設骨材市場) is poised to reach US$ 418.14 billion by 2024, with a projected Compound Annual Growth Rate (CAGR) of 6.5% from 2024 to 2034. The surge in global population has fueled construction activities, leading to a substantial demand for construction aggregates. Moreover, governments in developing nations are heavily investing in infrastructure development, further boosting the demand for construction aggregates. The launch of numerous mega projects
Chromatography Syringes Market to Experience Notable Growth by 2032
04-17-2024 | Health & Medicine
Fact.MR
Chromatography Syringes Market to Experience Notable Growth by 2032
The market research and competitive intelligence company Fact.MR recently released a report estimating that sales of Chromatography Syringes would reach a valuation of US$ 140 million by 2032, growing at a compound annual growth rate (CAGR) of roughly 6% between 2022 and 2032. Developments in chromatography syringe design and calibration, such as digitalization leading to appropriate sample pooling, are improving the performance of chromatography columns. These advancements offer benefits such faster
Sacroiliac Joint Fusion Market: An Overview of the Forecasted CAGR of 20.2% from 2022 to 2032
04-17-2024 | Health & Medicine
Fact.MR
Sacroiliac Joint Fusion Market: An Overview of the Forecasted CAGR of 20.2% from …
It is projected that the worldwide market for Sacroiliac Joint Fusion would be valued US$ 3,900 million by 2032, up from US$ 620 million in 2022. The market is anticipated to expand at a CAGR of 20.2% between 2022 and 2032. the rapid technological advancement in the healthcare industry and the growing demand for minimally invasive surgical treatments are responsible for the market's progress. orthopedic doctors at Yale Medicine frequently

All 5 Releases


More Releases for Peptide

Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology. Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample There are two main types of products available in the customized peptide synthesis
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology. Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future. Click to Request a Sample:
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug